![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/5575 | |
A61P 27/02 | |||
A61L 2/20 | |||
A61K 9/08 |
(11) | Number of the document | 1825855 |
(13) | Kind of document | T |
(96) | European patent application number | 05814731.5 |
Date of filing the European patent application | 2005-12-09 | |
(97) | Date of publication of the European application | 2007-08-29 |
(45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2005/022618 |
Date | 2005-12-09 |
(87) | Number | WO 2006/062184 |
Date | 2006-06-15 |
(30) | Number | Date | Country code |
2004356969 | 2004-12-09 | JP |
(72) |
KADO, Takehiro,, JP
OKAMOTO, Tomoyuki,, JP
ASADA, Hiroyuki,, JP
KIMURA, Akio,, JP
|
(73) |
SANTEN PHARMACEUTICAL CO., LTD.,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651,
JP
|
(54) | PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |
PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |